Prajwal Karmacharya

Prajwal Karmacharya has a diverse work experience in the field of quality assurance and operations. Prajwal is currently serving as the Director of Quality at Tessera Therapeutics since March 2022. Prior to this, they worked at Spectrum Pharmaceuticals, Inc. as an Associate Director, Quality Systems from August 2020 to March 2022. Before that, they held various roles at bluebird bio, including QA Operations Senior Manager from December 2019 to August 2020, and QA Operation Manager from August 2018 to December 2019. Prajwal also worked as a Commercial QA Manager at Takeda Oncology from May 2017 to August 2018 and as a QA Manager Supply Chain at Alnylam Pharmaceuticals from June 2016 to April 2017. Prajwal's earlier experience includes positions at Genzyme as a Senior Quality Engineer/Quality System Champion from 2014 to May 2016, as a Senior Quality Engineer from 2013 to 2014, and as a QA Operation Supervisor from 2011 to 2013. Prajwal began their career at AMRI, where they worked as a Manufacturing Operation Supervisor from 2009 to 2011, as a Process Engineer from 2008 to 2009, and as a QC Microbiology from 2007 to 2008.

Prajwal Karmacharya pursued a Bachelor of Science degree in Biology/Biological Sciences from Eastern Nazarene College from 2005 to 2007. Following that, they completed a Master of Science (MSc) in Regulatory Affairs from Northeastern University between 2009 and 2011. In 2013, Prajwal obtained a Master of Business Administration (M.B.A.) degree from the University of Massachusetts Lowell. Presently, Prajwal is studying at Touro University Worldwide, pursuing a Doctor of Management degree in the field of Management, expected to be completed in 2023. Additionally, Prajwal received the Investigations and CAPA Instructor Led Training certification from PathWise in January 2021.